Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Circulation|May 17, 2021
Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy (PRADA): Extended Follow-Up of a 2×2 Factorial, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Candesartan and MetoprololSiri Lagethon Heck, Albulena Mecinaj, Anne Hansen Ree, et al.
European Heart Journal. Cardiovascular Imaging|November 7, 2017
Effect of candesartan and metoprolol on myocardial tissue composition during anthracycline treatment: the PRADA trialSiri Lagethon Heck, Geeta Gulati, Pavel Hoffmann, et al.
European Heart Journal. Acute Cardiovascular Care|August 28, 2021
Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Consensus Document of the Acute CardioVascular Care (ACVC) association and the ESC council of Cardio-Oncology-Part 1: acute coronary syndromes and acute pericardial diseasesSofie A Gevaert, Sigrun Halvorsen, Peter R Sinnaeve, et al.
European Heart Journal. Cardiovascular Imaging|April 23, 2026
Multimodality imaging in the detection and management of coronary and peripheral arterial disease in patients with cancer receiving cardiotoxic antineoplastic treatments. A clinical consensus statement of the ESC Council of Cardio-Oncology and the European Association of Cardiovascular Imaging (EACVI) of the ESCGiuseppina Novo, Teresa Lopez-Fernandez, Victoria Delgado, et al.
Circulation|August 30, 2025
Sacubitril-Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: The PRADA II Randomized Clinical TrialTorbjørn Omland, Siri Lagethon Heck, Espen Holte, et al.
European Heart Journal|February 24, 2016
Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprololGeeta Gulati, Siri Lagethon Heck, Anne Hansen Ree, et al.
JACC. Advances|November 14, 2025
Prognostic Performance of a Modified HFA-ICOS Tool for Prediction of Cardiovascular Complications in Cancer PatientsMari Nordbø Gynnild, Victoria Vinje-Jakobsen, Joris Holtrop, et al.
European Heart Journal. Acute Cardiovascular Care|October 13, 2022
Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Clinical Consensus Statement of the Acute CardioVascular Care Association (ACVC) and the ESC council of Cardio-Oncology-part 2: acute heart failure, acute myocardial diseases, acute venous thromboembolic diseases, and acute arrhythmiasSofie A Gevaert, Sigrun Halvorsen, Peter R Sinnaeve, et al.
Journal of Clinical Pharmacology|July 6, 2025
Utilization of Proteomic Measures for Early Detection of Drug Benefits and Adverse EffectsJessica Chadwick, Colin Berry, Meredith A Carpenter, et al.
European Journal of Heart Failure|July 18, 2025
Prevention of cancer therapy-related cardiac dysfunction and heart failure in cancer patients and survivors. A Clinical Consensus Statement of the Heart Failure Association, the European Association of Preventive Cardiology of the ESC, and the ESC Council of Cardio-OncologyAmina Rakisheva, Dimitrios Farmakis, Andrea Attanasio, et al.
Pageof 3